retatrutide doses clinical trial ESC 2024: improves lipid and cardiovascular risk profile in Phase II retatrutide maximum dose clinical trials

Its always wise to consult with a healthcare provider before starting any new supplement, especially if you have underlying health conditions

RELATED: 6 Reasons to Talk to Your Doctor About GLP-1 If you think you need GLP-1 medication, then its best to talk to your doctor about your options

Semaglutide and tirzepatide have shown promising results in supporting long-term weight reduction

PMC 7653199

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes, Diabetes Spectrum, Aug

NAION is a very rare side effect of semaglutide, potentially affecting up to 1 in 10,000 users, the World Health Organization noted, citing the European Medicines Agency